16 research outputs found
all_phylogenetic_trees
The results of all 19 phylogenetic analyses conducted in this study. Each tree corresponds to an analysis described in Supplementary Table 4
nucleotide_gene_trees
Gene trees for all 21 loci sequenced in this study produced from codon alignment
all_alignments
All alignments (codon and amino acid) used for phylogenetic analyse
amino_acid_gene_trees
Gene trees for all 21 loci sequenced in this study produced from amino acid alignment
Recommended from our members
Targeting the non-canonical NF-?B pathway in chronic lymphocytic leukemia and multiple myeloma
In this study, we evaluated an NF-?B inducing kinase (NIK) inhibitor, CW15337, in primary chronic lymphocytic leukemia (CLL) cells, CLL and multiple myeloma (MM) cell lines and normal B-and T-lymphocytes. Basal NF-?B subunit activity was characterized using an enzyme linked immunosorbent assay (ELISA), and the effects of NIK inhibition were then assessed in terms of cytotoxicity and the expression of nuclear NF-?B subunits following monoculture and co-culture with CD40L-expressing fibroblasts, as a model of the lymphoid niche. CW15337 induced a dose-dependent increase in apoptosis, and nuclear expression of the non-canonical NF-?B subunit, p52, was correlated with sensitivity to CW15337 (p = 0.01; r2 = 0.39). Co-culture on CD40L-expressing cells induced both canonical and non-canonical subunit expression in nuclear extracts, which promoted in vitro resistance against fludarabine and ABT-199 (venetoclax) but not CW15337. Furthermore, the combination of CW15337 with fludarabine or ABT-199 showed cytotoxic synergy. Mechanistically, CW15337 caused the selective inhibition of non-canonical NF-?B subunits and the transcriptional repression of BCL2L1, BCL2A1 and MCL1 gene transcription. Taken together, these data suggest that the NIK inhibitor, CW15337, exerts its effects via suppression of the non-canonical NF-?B signaling pathway, which reverses BCL2 family-mediated resistance in the context of CD40L stimulation
MOESM1 of Parasitaemia data and molecular characterization of Haemoproteus catharti from New World vultures (Cathartidae) reveals a novel clade of Haemosporida
Additional file 1. Bayesian phylogenetic tree for select reptilian, avian and mammalian haemosporidians based on mitochondrial cytochrome b gene sequences. Branch lengths are drawn proportionally to evolutionary distance and posterior probability values are shown. GenBank or MalAvi ascension codes are provided for each sequence. Branches are colour coded by parasite host; avian species are blue, reptile hosts are green, and mammal hosts are pink
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic Release
<div><p>Human genetic studies show that the voltage gated sodium channel 1.7 (Na<sub>v</sub>1.7) is a key molecular determinant of pain sensation. However, defining the Na<sub>v</sub>1.7 contribution to nociceptive signalling has been hampered by a lack of selective inhibitors. Here we report two potent and selective arylsulfonamide Na<sub>v</sub>1.7 inhibitors; PF-05198007 and PF-05089771, which we have used to directly interrogate Na<sub>v</sub>1.7’s role in nociceptor physiology. We report that Na<sub>v</sub>1.7 is the predominant functional TTX-sensitive Na<sub>v</sub> in mouse and human nociceptors and contributes to the initiation and the upstroke phase of the nociceptor action potential. Moreover, we confirm a role for Na<sub>v</sub>1.7 in influencing synaptic transmission in the dorsal horn of the spinal cord as well as peripheral neuropeptide release in the skin. These findings demonstrate multiple contributions of Na<sub>v</sub>1.7 to nociceptor signalling and shed new light on the relative functional contribution of this channel to peripheral and central noxious signal transmission.</p></div
PF-05198007 reduces the capsaicin flare response in WT, but not Na<sub>v</sub>1.7<sup>Nav1.8Cre</sup> mice.
<p>A, B.Time-course plots showing the effects of PF-05198007 on skin blood flow measured before and after topical capsaicin application for WT (A) and Nav1.7<sup>Nav1.8Cre</sup> (B) mice (for each genotype, n = 8 per group). C, D. Corresponding summary bar graphs showing flare response measured as area under the curve for WT (C) and Nav1.7<sup>Nav1.8Cre</sup> (D) mice before and after PF-05198007 treatment. 1 mg/kg and 10 mg/kg PF-05198007 significantly reduced capsaicin-induced flare in WT mice (C, both 1 mg/kg and 10 mg/kg, p < 0.01, ANOVA) but had no effect in Na<sub>v</sub>1.7<sup>Nav1.8Cre</sup> mice (D, both 1 mg/kg and 10 mg/kg, p > 0.05, ANOVA).</p
Na<sub>v</sub>1.7 is the major TTX-sensitive Na<sub>v</sub> channel in small diameter mDRG neurons.
<p>A. RNASeq analysis of Na<sub>v</sub> channel mRNA from pooled small diameter mouse DRG neurons. B. Structure of PF-05198007 (4-(2-(3-amino-1H-pyrazol-4-yl)-4-(trifluoromethyl)phenoxy)-5-chloro-2-fluoro-N-(thiazol-4-yl)benzenesulfonamide C. Patch clamp data showing concentration-response relationship for PF-05198007 assessed against recombinantly expressed mouse Na<sub>v</sub>1.7, Na<sub>v</sub>1.6 and Na<sub>v</sub>1.1 (IC<sub>50</sub>, Slope: 5.2 nM, 1.1; 149 nM, 1.5; 174 nM, 0.7 respectively; n = 3–4 per concentration). D. Representative patch clamp current traces of peak sodium current from small diameter mouse DRG neurons in the presence of A-803467 and following concurrent application of PF-05198007 and TTX. E. Representative peak TTX-S current <i>vs</i> time plot before and after 30 nM PF-05198007 and 500 nM TTX. G. Scatter plot of cell capacitance <i>vs</i> Na<sub>v</sub>1.7/TTX-S ratio (n = 35). Note that in every cell tested, Na<sub>v</sub>1.7 provided the predominant TTX-S sodium conductance.</p
Evidence for functional Na<sub>v</sub>1.7 in human DRG neurons.
<p>A. Representative TTX-S current traces (recorded in the presence of 1 μM A-803467 and following graded voltage steps from -110 mV to 10 mV. B. Voltage dependence of activation (red, n = 4 for each voltage) generated from the protocol described in A and steady state fast inactivation (blue) generated by conditioning 500 msec prepulses to voltages between -110 mV and +10 mV followed by a test pulse to 0 mV from a holding potential of -110 mV (n = 4 for each voltage). Both datasets are fitted with Boltzmann functions. C. Representative timecourse relationship for peak TTX-S current following the application of 100 nM PF-05089771 and 500 nM TTX. D. Concentration-response relationship for PF-05089771 block of TTX-S current (IC<sub>50</sub>, slope: 8.4 nM, 1.1; n = 3–6 per concentration) E. Example voltage traces from a current clamp recording. Single action potentials were evoked by a 20 ms suprathreshold current step at 0.1 Hz. The scale bar refers to the voltage traces whereas the start-to-start interval is 10 s. F. Summary pie charts showing that the application of 30 and 100 nM PF-05089771 resulted in action potential block in 3/7 and 5/8 DRG neurons respectively.</p